🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Lushang Freda Pharmaceutical Co.,Ltd. (SHA:600223)
China flag China · Delayed Price · Currency is CNY
4.880
-0.200 (-3.94%)
Nov 20, 2026, 3:00 PM CST

SHA:600223 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
3,7863,6093,9444,51112,65912,201
Other Revenue
42.3642.3638.967.66292.87161.85
3,8293,6513,9834,57912,95112,363
Revenue Growth
1.37%-8.33%-13.02%-64.65%4.76%-9.20%
Cost of Revenue
1,6921,7321,8892,45710,0259,384
Gross Profit
2,1371,9192,0932,1212,9262,980
Selling, General & Admin
1,7681,5461,6461,6681,6611,628
Research & Development
164.33161.72166.77153.36133.92118.75
Other Operating Expenses
34.2127.5540.1536.42539.39585.63
Operating Expenses
1,9801,7461,8791,8942,3502,343
Operating Income
156.24173.29214.71227.71575.66636.91
Interest Expense
-4.11-5.84-22.12-94.75-400.97-112.32
Interest & Investment Income
79.7101.59115.8259.29163.61239.56
Currency Exchange Gain (Loss)
0.270.271.850.3212.59-1.14
Other Non Operating Income (Expenses)
-1.12-1.38-0.92-8-62.17-139.2
EBT Excluding Unusual Items
230.98267.93309.33384.56288.73623.82
Impairment of Goodwill
----1.85-4.74-3.98
Gain (Loss) on Sale of Assets
-3.22-0.230.42-1.120.44-0.04
Asset Writedown
-1.77-----
Other Unusual Items
15.6317.1736.5531.37-23.3723.93
Pretax Income
241.62284.88346.29412.96261.06643.73
Income Tax Expense
39.7147.3949.8546.82195.96249.93
Earnings From Continuing Operations
201.91237.48296.44366.1465.1393.8
Minority Interest in Earnings
-44.86-49.73-52.92-62.75-19.64-31.9
Net Income
157.04187.75243.53303.3945.46361.9
Net Income to Common
157.04187.75243.53303.3945.46361.9
Net Income Growth
-26.65%-22.90%-19.73%567.44%-87.44%-43.34%
Shares Outstanding (Basic)
1,0411,0431,0151,0111,1361,005
Shares Outstanding (Diluted)
1,0411,0431,0151,0111,1361,034
Shares Change
2.15%2.80%0.34%-11.01%9.90%2.00%
EPS (Basic)
0.150.180.240.300.040.36
EPS (Diluted)
0.150.180.240.300.040.35
EPS Growth
-28.19%-25.00%-20.00%650.00%-88.57%-44.44%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
180.72165.871.44262.79831.986,567
Free Cash Flow Per Share
0.170.160.070.260.736.35
Dividend Per Share
0.0570.0570.1100.1000.1100.110
Dividend Growth
-5.00%-48.18%10.00%-9.09%0%-45.00%
Gross Margin
55.81%52.57%52.56%46.33%22.59%24.10%
Operating Margin
4.08%4.75%5.39%4.97%4.45%5.15%
Profit Margin
4.10%5.14%6.12%6.63%0.35%2.93%
Free Cash Flow Margin
4.72%4.54%1.79%5.74%6.42%53.12%
EBITDA
265.3276.91311.09363.55692.15729.53
EBITDA Margin
6.93%7.58%7.81%7.94%5.34%5.90%
D&A For EBITDA
109.06103.6296.38135.84116.4992.62
EBIT
156.24173.29214.71227.71575.66636.91
EBIT Margin
4.08%4.75%5.39%4.97%4.45%5.15%
Effective Tax Rate
16.44%16.64%14.40%11.34%75.06%38.83%
Revenue as Reported
3,8293,6513,9834,57912,95112,363
Advertising Expenses
---784.1705.36630.15